[artículo] 
inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 597-602

Título :	A double blind, placebo-controlled trial of the NMDA glycine site antagonist, gw468816, for prevention of relapse to smoking in females
Tipo de documento:	texto impreso
Autores:	A. Eden Evins, Autor ; Gladys Pachas, Autor ; David Mischoulon, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 597-602
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Nicotina, Dejar de fumar, NMDA, Glutamato, Prevención de recaídas, Glicina
Resumen:	Relapse to smoking is common after initial abstinence with pharmacotherapy and behavioral support and represents a major clinical challenge. Although mechanisms underlying relapse to smoking have not been elucidated, preclinical studies suggest that glutamate receptors may be involved.
Link:	./index.php?lvl=notice_display&id=29355

[artículo] A double blind, placebo-controlled trial of the NMDA glycine site antagonist, gw468816, for prevention of relapse to smoking in females [texto impreso] / A. Eden Evins, Autor ; Gladys Pachas, Autor ; David Mischoulon, Autor . - 2022 . - pp. 597-602.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - pp. 597-602

Palabras clave:	Nicotina, Dejar de fumar, NMDA, Glutamato, Prevención de recaídas, Glicina
Resumen:	Relapse to smoking is common after initial abstinence with pharmacotherapy and behavioral support and represents a major clinical challenge. Although mechanisms underlying relapse to smoking have not been elucidated, preclinical studies suggest that glutamate receptors may be involved.
Link:	./index.php?lvl=notice_display&id=29355